The Online Investor
OLI Premium
Retiree Portfolio
Stock Option Ideas
Preferred Stock List
ChartZero.com

PARTNER NEWS:

Thu, Apr 3, 4:20 PM, Zacks
Good News for Keryx - Analyst Blog
Keryx Biopharmaceuticals received good news when the European Medicines Agency (EMA) determined its Marketing Authorization Application (MAA) for lead candidate Zerenex as valid.

Thu, Mar 13, 11:19 AM, Zacks
Wider Q4 Loss at Keryx - Analyst Blog
Keryx Biopharmaceuticals reported a loss of 21 cents in the fourth quarter of 2013, wider than the Zacks Consensus Estimate of a loss of 19 cents per share.

FREE registration required to continue...

You have viewed 6 pages within the last 6 hours. To continue, please register at The Online Investor for unlimited page views and our free weekly newsletter, by entering your name and email address below. Registration is absolutely free. By registering, you agree to the terms of our privacy policy, disclaimer, & terms of service.

Problems with your registration ''sticking?'' Enable your browser to receive our ''cookie'' to resolve. Other questions? Email us at: info@theonlineinvestor.com

Keryx Biopharmaceuticals Inc. (KERX) Page | The Online Investor | www.TheOnlineInvestor.com | Copyright © 1998 - 2014, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.